Position in ROIV
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$3,753,293
New position
Shares Held
135,498
first reported quarter
Ownership
0.019%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 83.20117539352057.ToString("F0")%
Shared 0.ToString("F0")%
None 16.79882460647943.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026GREAT LAKES ADVISORS, LLC holds $63,780,240 across 22 Biotechnology names. ROIV ranks #8 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
48,945 | $9,253,051 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
118,926 | $8,930,152 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,232 | $7,905,650 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
71,043 | $7,487,931 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
|
241,827 | $5,383,068 | |
| 6 | IDYA |
IDEAYA Biosciences, Inc.
|
141,048 | $4,699,719 | |
| 7 | DNLI |
Denali Therapeutics Inc.
|
227,110 | $4,360,512 | |
| 8 | ROIV |
Roivant Sciences Ltd.
This page
|
135,498 | $3,753,293 |
All Filings in ROIV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,753,293 | 135,498 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||